CA50114-1 - 0x0000000000006ABF

Males & Females of Non-Childbearing Potential

Note

* Stipend may pay up to reflected amount.
Start Date: 
March 16, 2026 - 10:00am
End Date: 
June 30, 2026 - 11:15am

Study Details

Study Number: CA50114
Group Number: 1
Study Requirement: Healthy Normal Male and Female
Stipend: up to $10,000.00

Study Criteria

Age: 18 - 55
BMI: 18 - 32
Weight Restriction: minimum weight 111 lbs

Study Information

Indication: This investigational medication is being developed to prevent and treat blood clots.
Route of Administration: Injection subcutaneous
Blood Draws: 19

Study Schedule

Schedule Type: Short stays with returns
Study Length: 5 Night Stay & 10 Returns

Screening Dates:

Event Day Event Date
Thursday 2/26/2026

Doctor Exam Dates:

Event Day Event Date
Thursday 2/26/2026

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Monday 3/16/2026 10:00:00 AM Saturday 3/21/2026 11:15:00 AM 1 Phoenix
Return Monday 3/23/2026 9:15:00 AM Monday 3/23/2026 11:15:00 AM 1 Phoenix
Return Thursday 3/26/2026 9:30:00 AM Thursday 3/26/2026 11:15:00 AM 1 Phoenix
Return Tuesday 3/31/2026 9:30:00 AM Tuesday 3/31/2026 11:15:00 AM 1 Phoenix
Return Tuesday 4/7/2026 9:30:00 AM Tuesday 4/7/2026 11:15:00 AM 1 Phoenix
Return Tuesday 4/14/2026 9:30:00 AM Tuesday 4/14/2026 11:15:00 AM 1 Phoenix
Return Tuesday 4/28/2026 9:30:00 AM Tuesday 4/28/2026 11:15:00 AM 1 Phoenix
Return Tuesday 5/12/2026 9:30:00 AM Tuesday 5/12/2026 11:15:00 AM 1 Phoenix
Return Tuesday 5/26/2026 9:30:00 AM Tuesday 5/26/2026 11:15:00 AM 1 Phoenix
Return Tuesday 6/9/2026 9:30:00 AM Tuesday 6/9/2026 11:15:00 AM 1 Phoenix
Return Tuesday 6/30/2026 9:15:00 AM Tuesday 6/30/2026 11:15:00 AM 1 Phoenix